Skip to main content
. 2018 Jun 5;6(3):185–192. doi: 10.1016/j.esxm.2018.03.001

Figure 4.

Figure 4

Forest plot for risk of non-arteritic anterior ischemic optic neuropathy after PDE5-I use within 1-year period. PDE5-I = phosphodiesterase type 5 inhibitor.